Nephros Operating Margin 2010-2025 | NEPH
Current and historical operating margin for Nephros (NEPH) over the last 10 years. The current operating profit margin for Nephros as of March 31, 2025 is 5.16%.
| Nephros Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.02B | $0.00B | 6.25% |
| 2024-12-31 | $0.02B | 0 | 0.00% |
| 2024-09-30 | $0.01B | $0.00B | -7.14% |
| 2024-06-30 | $0.01B | $0.00B | -7.14% |
| 2024-03-31 | $0.02B | $0.00B | -6.67% |
| 2023-12-31 | $0.02B | $0.00B | -6.67% |
| 2023-09-30 | $0.02B | $0.00B | -6.67% |
| 2023-06-30 | $0.01B | $0.00B | -15.38% |
| 2023-03-31 | $0.01B | $0.00B | -25.00% |
| 2022-12-31 | $0.01B | $-0.01B | -50.00% |
| 2022-09-30 | $0.01B | $0.00B | -40.00% |
| 2022-06-30 | $0.01B | $0.00B | -36.36% |
| 2022-03-31 | $0.01B | $0.00B | -40.00% |
| 2021-12-31 | $0.01B | $0.00B | -27.27% |
| 2021-09-30 | $0.01B | $0.00B | -40.00% |
| 2021-06-30 | $0.01B | $0.00B | -44.44% |
| 2021-03-31 | $0.01B | $-0.01B | -55.56% |
| 2020-12-31 | $0.01B | $-0.01B | -55.56% |
| 2020-09-30 | $0.01B | $0.00B | -40.00% |
| 2020-06-30 | $0.01B | $0.00B | -36.36% |
| 2020-03-31 | $0.01B | $0.00B | -27.27% |
| 2019-12-31 | $0.01B | $0.00B | -30.00% |
| 2019-09-30 | $0.01B | $0.00B | -44.44% |
| 2019-06-30 | $0.01B | $0.00B | -50.00% |
| 2019-03-31 | $0.01B | $0.00B | -57.14% |
| 2018-12-31 | $0.01B | $0.00B | -66.67% |
| 2018-09-30 | $0.01B | $0.00B | -60.00% |
| 2018-06-30 | $0.00B | $0.00B | -75.00% |
| 2018-03-31 | $0.00B | $0.00B | -75.00% |
| 2017-12-31 | $0.00B | $0.00B | -75.00% |
| 2017-09-30 | $0.00B | $0.00B | -100.00% |
| 2017-06-30 | $0.00B | $0.00B | -133.33% |
| 2017-03-31 | $0.00B | $0.00B | -133.33% |
| 2016-12-31 | $0.00B | $0.00B | -133.33% |
| 2016-09-30 | $0.00B | $0.00B | -133.33% |
| 2016-06-30 | $0.00B | $0.00B | -133.33% |
| 2016-03-31 | $0.00B | $0.00B | -133.33% |
| 2015-12-31 | $0.00B | $0.00B | -133.33% |
| 2015-09-30 | $0.00B | $0.00B | -200.00% |
| 2015-06-30 | $0.00B | $0.00B | -200.00% |
| 2015-03-31 | $0.00B | $0.00B | -400.00% |
| 2014-12-31 | $0.00B | $0.00B | 0.00% |
| 2014-09-30 | $0.00B | $0.00B | 0.00% |
| 2014-06-30 | $0.00B | $0.00B | 0.00% |
| 2014-03-31 | $0.00B | $0.00B | -400.00% |
| 2013-12-31 | $0.00B | $0.00B | -200.00% |
| 2013-09-30 | $0.00B | $0.00B | -200.00% |
| 2013-06-30 | $0.00B | $0.00B | -133.33% |
| 2013-03-31 | $0.00B | $0.00B | -200.00% |
| 2012-12-31 | $0.00B | $0.00B | -200.00% |
| 2012-09-30 | $0.00B | $0.00B | -200.00% |
| 2012-06-30 | $0.00B | $0.00B | -300.00% |
| 2012-03-31 | $0.00B | $0.00B | -150.00% |
| 2011-12-31 | $0.00B | $0.00B | -150.00% |
| 2011-09-30 | $0.00B | $0.00B | -100.00% |
| 2011-06-30 | $0.00B | $0.00B | -75.00% |
| 2011-03-31 | $0.00B | $0.00B | -50.00% |
| 2010-12-31 | $0.00B | $0.00B | -50.00% |
| 2010-09-30 | $0.00B | $0.00B | -100.00% |
| 2010-06-30 | $0.00B | $0.00B | -75.00% |
| 2010-03-31 | $0.00B | $0.00B | -50.00% |
| 2009-12-31 | $0.00B | $0.00B | -50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.032B | $0.014B |
| Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.878B | 26.72 |
| Boston Scientific (BSX) | United States | $152.546B | 36.38 |
| Stryker (SYK) | United States | $143.342B | 29.18 |
| EssilorLuxottica (ESLOY) | France | $134.414B | 0.00 |
| Medtronic (MDT) | Ireland | $114.542B | 16.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.355B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.554B | 23.72 |
| ResMed (RMD) | United States | $41.123B | 29.37 |
| Agilent Technologies (A) | United States | $32.165B | 20.97 |
| GE HealthCare Technologies (GEHC) | United States | $31.941B | 15.01 |
| Terumo (TRUMY) | Japan | $25.643B | 33.31 |
| Koninklijke Philips (PHG) | Netherlands | $25.229B | 16.69 |
| Insulet (PODD) | United States | $19.515B | 76.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.034B | 11.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.548B | 0.00 |
| Baxter (BAX) | United States | $11.546B | 8.93 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.193B | 26.27 |
| Prestige Consumer Healthcare (PBH) | United States | $3.714B | 16.59 |
| Haemonetics (HAE) | United States | $3.640B | 16.58 |
| Lantheus Holdings (LNTH) | United States | $3.589B | 9.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.275B | 22.92 |
| Perrigo (PRGO) | Ireland | $3.246B | 8.11 |
| ICU Medical (ICUI) | United States | $3.123B | 23.03 |
| LeMaitre Vascular (LMAT) | United States | $2.106B | 45.26 |
| AtriCure (ATRC) | United States | $1.815B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.585B | 10.02 |
| Green Thumb Industries (GTBIF) | United States | $1.454B | 62.46 |
| AdaptHealth (AHCO) | United States | $1.329B | 18.94 |
| Acuren (TIC) | United States | $1.217B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.126B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.074B | 13.73 |
| Neogen (NEOG) | United States | $1.036B | 16.45 |
| BioLife Solutions (BLFS) | United States | $1.009B | 0.00 |
| InMode (INMD) | Israel | $0.884B | 8.18 |
| Kestra Medical Technologies (KMTS) | United States | $0.743B | 0.00 |
| Valneva SE (VALN) | France | $0.697B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.621B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.46 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.497B | 4.12 |
| CeriBell (CBLL) | United States | $0.462B | 0.00 |
| SNDL (SNDL) | Canada | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.412B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.354B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.290B | 10.67 |
| Quanterix (QTRX) | United States | $0.280B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.278B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.255B | 18.97 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Omeros (OMER) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.20 |
| Sanara MedTech (SMTI) | United States | $0.218B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| Biote (BTMD) | United States | $0.211B | 6.33 |
| Exagen (XGN) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.194B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.04 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.150B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Safety Shot (SHOT) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.27 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.75 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Veru (VERU) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 12.60 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |